Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 200.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 50.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bordetella bronchiseptica | corynebacterium spp. | escherichia coli (e. coli) | klebsiella spp. | pasteurella spp. | proteus mirabilis | salmonella | staphylococcus spp. | streptococcus spp. | bacterial canker | canine cough syndrome | including b-lactamase producin | infectious tracheobronchitis | pasterellosis | pasteurellosis | salmonellosis | staphylococcosis

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 400.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 100.0 mg/tb - antibiotic & related - calf | dog | beef calf | bitch | bovine | calf - poddy | calf - preweaning | calf - sucker | castrate | dairy calf | neonatal ca - bordetella bronchiseptica | corynebacterium spp. | escherichia coli (e. coli) | klebsiella spp. | pasteurella spp. | proteus mirabilis | salmonella | staphylococcus spp. | streptococcus spp. | bacterial canker | canine cough syndrome | including b-lactamase producin | infectious tracheobronchitis | pasterellosis | pasteurellosis | salmonellosis | staphylococcosis

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 40.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 10.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bordetella bronchiseptica | corynebacterium spp. | escherichia coli (e. coli) | klebsiella spp. | pasteurella spp. | proteus mirabilis | salmonella | staphylococcus spp. | streptococcus spp. | bacterial canker | canine cough syndrome | including b-lactamase producin | infectious tracheobronchitis | pasterellosis | pasteurellosis | salmonellosis | staphylococcosis

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - amoxycillin as amoxycillin trihydrate - parenteral liquid/solution/suspension - amoxycillin as amoxycillin trihydrate antibiotic active 150.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotics - oral, parenteral | bacillus anthracis | bacterial infection | bordetella bronchiseptica | clostridium spp. | corynebacterium spp. | escherichia coli (e. coli) | fusobacterium spp. | proteus mirabilis | salmonella spp. | staphylococcus - not penicillin resist | streptococci | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacteria | anaerobic bacterial infection | anthrax | associated with viral disease | avian mycoplasmas | bacterial canker | canine cough syndrome | clavulanic acid sensitive | clostridium botulinum | clostridium chauvoei | clostridium fallax | clostridium feseri | clostridium hemolyticum | clostridium novyi | clostridium perfringens types | clostridium septicum | clostridium sordelli | clostridium sporogenes | clostridium tetani | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | excluding penicillin resistant | gentamicin sensitive | gram negative organisms | gram positi

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 75.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 25.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - orbifloxacin - oral tablet - orbifloxacin antibiotic active 6.25 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - acinetobacter spp. | enterobacter spp. | enterococcus faecalis | escherichia coli (e. coli) | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas spp. | staphylococcus intermedius | streptococcus - hemolytic group g | deep pyodermas | fowl cholera | including b-lactamase producin | including secondary invaders | seborrhoeic dermatitis

Izrael - angličtina - Ministry of Health

novartis israel ltd - cefazolin as sodium - powder for solution for injection - cefazolin as sodium 1 g/vial - cefazolin - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella species and staphylococcus aureus. bone and joint :infections due to staphylococcus aureus. genital infections (i.e. prostatitis epididymitis) due to escherichia coli proteus mirabilis klebsiella species and some strains of enterococci.septicemia due to streptococcus pneumoniae (formerly diplococcus pneumoniae) staphylococcus aureus (penicillin-sensitive and penicillin-resistant) proteus mirabilis escherichia coli and klebsiella species.endocarditis caused by staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a beta-hemolytic streptococci. appropriate culture and susceptibility studies should be performed to determine the susceptibility of the causative organism to cefazolin.perioperative prophylaxis: the prophylactic administraton of cefazolin perioperatively (preoperatively intraoperatively and postoperatively) may reduce the incidence of certain postoperative infectons in patients undergoing surgical procedures (e.g. hysterectomy gastrointestinal surgery and transurethral prostatectomy) that are classified as contaminated or potentially contaminated. the perioperative use of cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. open-heart surgery and prosthetic arthroplasty).

Izrael - angličtina - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate; tobramycin - ophthalmic suspension - tobramycin 3 mg/ml; loteprednol etabonate 5 mg/ml - tobramycin - tobramycin - zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.the particular anti-infective drug in this product (tobramycin) is active against the following common bacterial eye pathogens:staphylococci, including s. aureus and s. epidermidis (coagulase-positive and coagulase-negative), including penicillin-resistant strains. streptococci, including some of the group a-beta-hemolytic species, some nonhemolytic species, and some streptococcus pneumoniae. pseudomonas aeruginosa, escherichia coli, klebsiella pneumoniae, enterobacter aerogenes, proteus mirabilis, morganella morganii, most proteus vulgaris strains, haemophilus influenzae, and h. aegyptius, moraxella lacunata, acinetobacter calcoaceticus and some neisseria species.

Evropská unie - angličtina - EMA (European Medicines Agency)

intervet international bv - ibafloxacin - antibacterials for systemic use - dogs; cats - dogs:ibaflin is indicated for the treatment of the following conditions in dogs:dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains of staphylococci, escherichia coli and proteus mirabilis;acute, uncomplicated urinary-tract infections, caused by susceptible strains of staphylococci, proteus species, enterobacter spp., e. coli and klebsiella spp.;respiratory-tract infections (upper tract) caused by susceptible strains of staphylococci, e. coli, and klebsiella spp.ibaflin gel is indicated in dogs for the treatment of the following conditions:dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as staphylococcus spp., e. coli and p. mirabilis.cats:ibaflin gel is indicated in cats for treatment of the following conditions:dermal infections (soft-tissue infections - wounds, abscesses) caused by susceptible pathogens such as staphylococcus spp., e. coli, proteus spp. and pasteurella spp.;upper respiratory-tract infections caused by susceptible pathogens such as staphylococcus spp., e. coli, klebsiella spp. and pasteurella spp.